Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study

Annals of Pharmacotherapy

Volumn 50, Issue 2, 2016, Pages 89-95

  Wimmer, Barbara C ^a   Bell, J Simon ^a,b   Fastbom, Johan ^c   Wiese, Michael D ^b   Johnell, Kristina ^c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

aged; cohort study; death; medication regimen complexity; polypharmacy

Indexed keywords

65 ITEM MEDICATION REGIMEN COMPLEXITY INDEX; ADULT; AGE; AGED; ARTICLE; ASSESSMENT OF HUMANS; CAUSE OF DEATH; COGNITION; COHORT ANALYSIS; DRUG THERAPY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MEDICATION REGIMEN COMPLEXITY; MINI MENTAL STATE EXAMINATION; MORTALITY; POLYPHARMACY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX DIFFERENCE; TASK PERFORMANCE; VERY ELDERLY; DAILY LIFE ACTIVITY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

DRUG;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; PROPORTIONAL HAZARDS MODELS;

EID: 84954357643     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028015621071     Document Type: Article

References (36)

1. C.J.CharlesworthE.SmitD.S.LeeF.AlramadhanM.C.OddenPolypharmacy among adults aged 65 years and older in the United States: 1988-2010. J Gerontol A Biol Sci Med Sci. 2015;70:989-995. doi:10.1093/gerona/glv013.
2. B.GuthrieB.MakubateV.Hernandez-SantiagoT.DreischulteThe rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015;13:74. doi:10.1186/s12916-015-0322-7.
3. L.D.HughesM.E.McMurdoB.GuthrieGuidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42:62-69. doi:10.1093/ageing/afs100.
4. M.N.WillsonC.L.GreerD.L.WeeksMedication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacother. 2014;48:26-32. doi:10.1177/1060028013510898.
5. S.T.de VriesJ.C.KeersR.Visser. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76:134-138. doi:10.1016/j.jpsychores.2013.11.003.
6. B.C.WimmerE.DentR.Visvanathan. Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study. Drugs Aging. 2014;31:623-630. doi:10.1007/s40266-014-0185-1.
7. M.T.DierichC.MuellerB.L.WestraMedication regimens in older home care patients. J Gerontol Nurs. 2011;37:45-55. doi:10.3928/00989134-20111103-02.
8. R.RuiterL.E.VisserE.M.RodenburgG.TrifiroG.ZiereB.H.StrickerAdverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands. Drugs Aging. 2012;29:225-232. doi:10.2165/11599430-000000000-00000.
9. J.GeorgeY.T.PhunM.J.BaileyD.C.KongK.StewartDevelopment and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38:1369-1376.
10. T.R.FriedJ.O’LearyV.TowleM.K.GoldsteinM.TrentalangeD.K.MartinHealth outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261-2272. doi:10.1111/jgs.13153.
11. M.K.RichardsonA.AnanouL.LafortuneC.BrayneF.E.MatthewsVariation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 2011;28:547-560. doi:10.2165/11592000-000000000-00000.
12. B.C.WimmerK.JohnellJ.FastbomM.WieseJ.S.BellFactors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol. 2015;71:1099-1108. doi:10.1007/s00228-015-1883-2.
13. G.SantoniS.AnglemanA.-K.WelmerF.MangialascheA.MarengoniL.FratiglioniAge-related variation in health status after age 60. PLoS One. 2015;10:e0120077. doi:10.1371/journal.pone.0120077.
14. British National Formulary. British Medical Association and the Royal Pharmaceutical Society of Great Britain. 61st ed. London, UK: BMJ; 2011.
15. The electronic Medicines Compendium (eMC). http://www.medicines.org.uk/emc/. Accessed April 4, 2014.
16. C.E.S.Chris PirieBiotext Pty Ltd, ACT, eds. Australian Pharmaceutical Formulary and Handbook. 22nd ed.Canberra, Australia: Pharmaceutical Society of Australia; 2012.
17. B.C.WimmerE.DentJ.S.Bell. Medication regimen complexity and unplanned hospital readmissions in older people. Ann Pharmacother. 2014;48:1120-1128.
18. N.HammarL.AlfredssonM.RosenC.-L.SpetzT.KahanA.-S.YsbergA national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol. 2001;30:S30.
19. S.KatzA.B.FordR.W.MoskowitzB.A.JacksonM.W.JaffeStudies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
20. M.E.CharlsonP.PompeiK.L.AlesC.R.MacKenzieA new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
21. I.KlarinA.WimoJ.FastbomThe association of inappropriate drug use with hospitalisation and mortality. Drugs Aging. 2005;22:69-82.
22. M.F.FolsteinS.E.FolsteinP.R.McHugh“Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Y.HaasumJ.FastbomL.FratiglioniI.KareholtK.JohnellPain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs Aging. 2011;28:283-293.
24. N.KandiahA.ZhangD.C.Bautista. Early detection of dementia in multilingual populations: Visual Cognitive Assessment Test (VCAT) [published online February17, 2015]. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-309647.
25. S.H.SimpsonD.T.EurichS.R.Majumdar. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.
26. D.S.BudnitzM.C.LovegroveN.ShehabC.L.RichardsEmergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002-2012. doi:10.1056/NEJMsa1103053.
27. K.H.GroenewegenA.M.ScholsE.F.WoutersMortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459-467.
28. I.A.ScottS.N.HilmerE.Reeve. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175:827-834. doi:10.1001/jamainternmed.2015.0324.
29. A.OksuzyanK.JuelJ.W.VaupelK.ChristensenMen: good health and high mortality. Sex differences in health and aging. Aging Clin Exp Res. 2008;20:91-102.
30. F.FranconiI.CampesiPharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol. 2014;171:580-594. doi:10.1111/bph.12362.
31. D.MarazzitiS.BaroniM.Picchetti. Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex. CNS Spectr. 2013;18:118-127. doi:10.1017/s1092852912001010.
32. O.P.SoldinD.R.MattisonSex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48:143-157. doi:10.2165/00003088-200948030-00001.
33. D.GnjidicS.N.HilmerS.Hartikainen. Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer’s disease: a national population cohort study. PLoS One. 2014;9:e83224. doi:10.1371/journal.pone.0083224.
34. T.J.van der CammenC.RajkumarG.OnderC.S.SterkeM.PetrovicDrug cessation in complex older adults: time for action. Age Ageing. 2014;43:20-25. doi:10.1093/ageing/aft166.
35. D.GarfinkelS.Zur-GilJ.Ben-IsraelThe war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9:430-434.
36. K.H.PitkäläA.-L.JuolaH.Kautiainen. Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. J Am Med Dir Assoc. 2014;15:892-898. doi:10.1016/j.jamda.2014.04.002.